Saturday March 25, Florence

Saturday March 25, Florence

00.01 - 23.59
WCO-IOF-ESCEO
08.00 - 09.00
EDUCATIONAL LECTURE
Meeting Room 3
Patient-reported outcomes : is this the future for the development of treatments in musculoskeletal diseases
‣ Maarten Boers
08.00 - 09.00
NON-SPONSORED SYMPOSIA
Meeting Room 1
Osteosarcopenia: a practical approach for the prevention of falls and osteoporotic fractures
Chairperson: ‣ Gustavo Duque
‣ Introduction Gustavo Duque
‣ Clinical and biochemical phenotype of osteosarcopenia Alberto Frisoli
‣ Musculoskeletal imaging and osteosarcopenia Neil Binkley
‣ Therapeutic interventions for osteosarcopenia Gustavo Duque
‣ Questions & Answers All
Meeting Room 2
How can exercise counter muscle weakness in the aged?
Chairperson: ‣ Ivan Bautmans
‣ Muscle weakness and fatigue: does the type of contraction matter? Liza De Dobbeleer
‣ Can exercise counter muscle activation deficits? Pauline Arnold
‣ Strength gain and functional benefits of resistance training: dose-response relationship Evelien Van Roie
Meeting Room 4
Closing the gap in the assessment of quality of life in sarcopenia
Chairpersons: ‣ Olivier Bruyère, ‣ Francesco Landi
‣ Importance of patient-centred outcomes (PCOs) in the assessment of chronic disorders Francesca Cerreta
‣ Assessment of quality of life in sarcopenia: what can we learn from osteoporosis? René Rizzoli
‣ SarQoL: a validated tool for the assessment of quality of life in sarcopenia Charlotte Beaudart
Meeting Room 6
Chronic Imuno-inflammation and bone structure
Chairpersons: ‣ Osvaldo D. Messina, ‣ Cristiano A. F. Zerbini
‣ Introduction – Inflammation and bone structure Cristiano A. F. Zerbini
‣ Published data related to biologic agents and bone loss in chronic arthritis Osvaldo D. Messina
‣ Quantification and Impact of Secondary Osteoarthritis using HR-pQCT in Anti-citrullinated protein antibody Rheumatoid Arthritis Patients Camille Figueiredo
‣ Bone impairment assessed using HR-pQCT and vertebral fractures in juvenile systemic lupus erythematosus Rosa Maria Pereira
‣ Discussion Osvaldo D. Messina
Meeting Room 7
Long-Term Therapy - Clinical Practice Cavaets
Chairperson: ‣ Bruno Muzzi Camargos
‣ Treatment Evidences Beyond 5 years Oscar Rosero Olarte
‣ Treatment failure Luis Fernando Vidal Neira
‣ Bone Imaging and Biochemical Monitoring on Long-Term Treated Patients Bruno Muzzi Camargos
‣ What happen after stopping denosumab Maria Belen Zanchetta
Meeting Room 8
Parental influences on offspring bone: Multidisciplinary evidence
Chairperson: ‣ Sharon L. Brennan‑Olsen
‣ Introduction to symposium session by Chair Sharon L. Brennan‑Olsen
‣ Life-course epidemiology: Developmental Origins of Health and Disease Natalie Hyde
‣ Animal models: Adverse conditions in utero and bone Ahmed Al Saedi
‣ Public health: Health literacy, role modelling and prevention Sarah Hosking
‣ Moderated panel discussion, and audience questions All
08.00 - 09.00
ESCEO Symposium under the auspices of WHO-EUGMS-IAGG-GARN and IOF
Meeting Room 5
Does nutrition play a role in the prevention and management of sarcopenia?
Chairpersons: ‣ Maria Luisa Brandi, ‣ Roger A. Fielding
‣ Welcome Islene Araujo de Carvalho
‣ Scope of the meeting Matteo Cesari
‣ Role of proteins Luc J. C. van Loon
‣ Role of calcium, dairy products and vitamin D Heike A. Bischoff‑Ferrari
‣ Role of other nutrients Yves Rolland
‣ Discussion - Leader: ‣ DiscussionMarjolein Visser
‣ Wrap-up Roger A. Fielding
Panel: ‣ Sophie Allepaerts, ‣ Nasser Al‑Daghri, ‣ Jotheeswaran Amuthavalli Thiyagarajan, ‣ Islene Araujo de Carvalho, ‣ Ivan Bautmans, ‣ John Beard, ‣ Heike A. Bischoff‑Ferrari, ‣ Maria Luisa Brandi, ‣ Olivier Bruyère, ‣ Tommy Cederholm, ‣ Francesca Cerreta, ‣ Matteo Cesari, ‣ Antonio Cherubini, ‣ Cyrus Cooper, ‣ Alfonso Cruz Jentoft, ‣ Bess Dawson‑Hughes, ‣ Roger A. Fielding, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Francesco Landi, ‣ Andrea Laslop, ‣ Alessandro Laviano, ‣ Stefania Maggi, ‣ Vincenzo Malafarina, ‣ Eugene McCloskey, ‣ Jean Petermans, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Sian Robinson, ‣ Yves Rolland, ‣ Ricardo Rueda, ‣ Luc J. C. van Loon, ‣ Bruno Vellas, ‣ Marjolein Visser
09.00 - 12.00
Auditorium A
SCIENTIFIC SESSION III
Chairpersons: ‣ Eugene McCloskey, ‣ Olivier Bruyère
09.00
Auditorium A
Plenary Lecture 5
‣ Can we improve bone health through nutrition? Cyrus Cooper
09.30
Auditorium A
Oral communications selected from abstracts
09.30
Auditorium A
OC18
‣ ABALOPARATIDE-SC FOR POSTMENOPAUSAL OSTEOPOROSIS: ANALYSIS OF THE NUMBER NEEDED TO TREAT COMPARED WITH TERIPARATIDE
Presenting author: ‣ J.‑Y. Reginster
Authors: ‣ D. M. Black, ‣ G. Hattersley, ‣ G. Williams, ‣ M. Hu, ‣ L. A. Fitzpatrick, ‣ E. M. Lewiecki
09.40
Auditorium A
OC19
‣ A RANDOMIZED, OPEN-LABEL PHASE 2 STUDY OF KRN23, AN INVESTIGATIONAL FULLY HUMAN ANTI-FGF23 MONOCLONAL ANTIBODY, IN CHILDREN WITH X-LINKED HYPOPHOSPHATEMIA (XLH): 64-WEEK RESULTS
Presenting author: ‣ T. Carpenter
Authors: ‣ E. A. Imel, ‣ A. Boot, ‣ W. Högler, ‣ A. Linglart, ‣ R. Padidela, ‣ W. van't Hoff, ‣ M. Whyte, ‣ M. Mao, ‣ A. Skrinar, ‣ J. San Martin, ‣ A. A. Portale
09.50
Auditorium A
OC20
‣ EFFECT OF 10 YEARS OF DENOSUMAB TREATMENT ON BONE HISTOLOGY AND HISTOMORPHOMETRY IN THE FREEDOM EXTENSION STUDY
Presenting author: ‣ D. W.  Dempster
Authors: ‣ N. Daizadeh, ‣ A. Fahrleitner‑Pammer, ‣ J.‑E. Beck Jensen, ‣ D. Kendler, ‣ I. Valter, ‣ R. B. Wagman, ‣ S. Yue, ‣ J. P. Brown
10.00
Auditorium A
OC21
‣ REDUCTION IN FRACTURE RATES WITH DENOSUMAB COMPARED TO ALENDRONATE IN TREATMENT NAÏVE PATIENTS: A PROPENSITY-MATCHED ‘REAL WORLD’ COHORT AND INSTRUMENTAL VARIABLE ANALYSIS
Presenting author: ‣ D. Prieto‑Alhambra
Authors: ‣ M. S. Ali, ‣ A. Judge, ‣ N. K. Arden, ‣ T. P. Van Staa, ‣ C. Cooper, ‣ K. Javaid, ‣ S. Khalid
10.10
Auditorium A
OC22
‣ A FRACTURE LIAISON SERVICE UTILIZING EMERGENCY DEPARTMENT INFORMATION SYSTEMS TO IDENTIFY PATIENTS WITH FRAGILITY FRACTURE IMPROVED TREATMENT AND RECURRENT FRACTURE RATES AND IS COST EFFECTIVE: A 12 MONTH ANALYSIS
Presenting author: ‣ C. Inderjeeth
Authors: ‣ W. Raymond, ‣ A. Briggs, ‣ E. Geelhoed, ‣ D. Oldham, ‣ J. McQuade, ‣ K. Briffa, ‣ D. Mountain
10.20
Auditorium A
OC23
‣ A BONE SPECIFIC PERIOSTIN FRAGMENT IS ASSOCIATED WITH INCIDENT FRACTURES RISK IN POST-MENOPAUSAL WOMEN FROM THE GERICO COHORT
Presenting author: ‣ N. Bonnet
Authors: ‣ E. Biver, ‣ T. Chevalley, ‣ R. Rizzoli, ‣ P. Garnero, ‣ S. Ferrari
10.30
Auditorium A
Plenary Lecture 6
‣ Calcium and Vitamin D : the true story Bess Dawson‑Hughes
11.00
Auditorium A
Oral communications selected from abstracts
11.00
Auditorium A
OC24
‣ IMPACT OF SARCOPENIA ON FUNCTIONAL OUTCOMES AMONG OLDER HIP-FRACTURED PATIENTS UNDERGOING IN-HOSPITAL REHABILITATION
Presenting author: ‣ R. Calvani
Authors: ‣ E. Marzetti, ‣ E. Ortolani, ‣ S. Salini, ‣ A. M. Martone, ‣ A. Picca, ‣ F. Landi
11.10
Auditorium A
OC25
‣ HEALTH OUTCOMES OF SARCOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Presenting author: ‣ C. Beaudart
Authors: ‣ M. Zaaria, ‣ F. Pasleau, ‣ J.‑Y. Reginster, ‣ O. Bruyère
11.20
Auditorium A
OC26
‣ ECONOMIC BURDEN ASSOCIATED WITH SARCOPENIA: ESTIMATIONS FROM AN ENGLISH COHORT STUDY
Presenting author: ‣ L. D. Westbury
Authors: ‣ R. Pinedo‑Villanueva, ‣ H. E. Syddall, ‣ M. T.  Sanchez‑Santos, ‣ E. M. Dennison, ‣ S. M. Robinson, ‣ C. Cooper
11.30
Auditorium A
OC27
‣ SARCOPENIA DOES NOT PREDICT ONE-YEAR-MORTALITY AFTER A HIP FRACTURE
Presenting author: ‣ A. Merello‑de‑Miguel
Authors: ‣ C. Miret‑Corchado, ‣ C. Sanchez‑Castellano, ‣ M. N.  Vaquero‑Pinto, ‣ A. C. Ramirez‑Archundia, ‣ A. J. Cruz Jentoft
11.40
Auditorium A
OC28
‣ INTEREST IN 10 CURRENT DEFINITIONS OF FRAILTY TO PREDICT THE INCIDENCE OF FALLS AND DEATHS AMONG ELDERLY NURSING HOME RESIDENTS
Presenting author: ‣ F. Buckinx
Authors: ‣ C. Lenaerts, ‣ T. Brunois, ‣ X. Rygaert, ‣ J.‑Y. Reginster, ‣ J. Petermans, ‣ O. Bruyère
11.50
Auditorium A
OC29
‣ EFFECTS OF 24 MONTHS TREATMENT OF TERIPARATIDE COMPARED WITH RISEDRONATE ON NEW FRACTURES IN POSTMENOPAUSAL WOMEN WITH SEVERE OSTEOPOROSIS: A RANDOMIZED, DOUBLE-DUMMY, CLINICAL TRIAL
Presenting author: ‣ D. L. Kendler
Authors: ‣ C. A. F. Zerbini, ‣ L. Russo, ‣ S.  Greenspan, ‣ V. Zikan, ‣ A. Bagur, ‣ J. Malouf, ‣ P.  Lakatos, ‣ A. Fahrleitner‑Pammer, ‣ E. Lespessailles, ‣ S. Minisola, ‣ J.‑J. Body, ‣ P. Geusens, ‣ R. Moericke, ‣ P. Lopez‑Romero, ‣ F. Marin
14.00 - 15.00
MEET-THE-EXPERT SESSIONS
Meeting Room 2
Rare bone disease: approaches to classification
‣ Kassim Javaid
Meeting Room 1
Management of corticosteroid-induced osteoporosis
‣ Emmanuel Biver
Meeting Room 4
Connected devices in musculo-skeletal health
‣ Olivier Bruyère, ‣ Daniel Pinto
14.00 - 15.00
Poster area
Poster Viewing Session II
14.00 - 15.10
Podium
Oral presentation of selected posters
Chairperson: ‣ Elaine M. Dennison
14.00
Podium
P266
‣ BONE QUALITY ASSESSMENT AMONG SARCOPENIC AND NON-SARCOPENIC ELDERLY SUBJECTS FROM THE SARCOPHAGE STUDY
Presenting author: ‣ M. Locquet
Authors: ‣ C. Beaudart, ‣ L. Delandsheere, ‣ J.‑Y. Reginster, ‣ J. A. Kanis, ‣ O. Bruyère
14.07
Podium
P216
‣ RELATIONSHIPS BETWEEN MARKERS OF INFLAMMAGING AND MUSCLE MASS, STRENGTH AND FUNCTION: RESULTS FROM THE HERTFORDSHIRE COHORT STUDY
Presenting author: ‣ L. D. Westbury
Authors: ‣ N. R. Fuggle, ‣ H. E. Syddall, ‣ N. A. Duggal, ‣ E. M. Dennison, ‣ J. Lord, ‣ C. Cooper
14.14
Podium
P152
‣ CHARACTERIZATION OF MOLECULAR PROFILE OF SARCOPENIA IN OSTEOPOROTIC AND OSTEOARTHRITIC PATIENTS
Presenting author: ‣ J. Baldi
Authors: ‣ M. Scimeca, ‣ E. Bonanno, ‣ E. Piccirilli, ‣ E. Gasbarra, ‣ R. Iundusi, ‣ U. Tarantino
14.21
Podium
P220
‣ ADHERENCE TO A MEDITERRANEAN DIET IS ASSOCIATED WITH LOWER INCIDENCE OF FRAILTY: DATA FROM THE OSTEOARTHRITIS INITIATIVE
Presenting author: ‣ N. Veronese
Authors: ‣ B. Stubbs, ‣ M. Noale, ‣ M. Solmi, ‣ R. Rizzoli, ‣ G. Crepaldi, ‣ S. Maggi
14.28
Podium
P128
‣ HEALTH BENEFITS AND CONSEQUENCES OF THE EASTERN ORTHODOX FASTING IN MONKS OF MOUNT ATHOS: A CROSS- SECTIONAL STUDY
Presenting author: ‣ A. Persynaki
Authors: ‣ S. Karras, ‣ A. Petroczi, ‣ E. Barkans, ‣ H. Mulrooney, ‣ M. Kypraiou, ‣ T. Tzotzas, ‣ K. Tziomalos, ‣ K. Kotsa, ‣ A. Tsioudas, ‣ C. Pichard, ‣ D. Naughton
14.35
Podium
P804
‣ VITAMIN D CORRECTION IMPROVES APOLIPOPROTEIN LEVELS IN A SEX-SPECIFIC MANNER
Presenting author: ‣ N. Al‑Daghri
Authors: ‣ M. Alokail, ‣ A. Manousopoulpou, ‣ A. Heinson, ‣ O. Al‑Attas, ‣ Y. Al‑Saleh, ‣ S. Sabico, ‣ N. Aljohani, ‣ C. Woelk, ‣ G. Chrousos, ‣ S. Garbis
14.42
Podium
P372
‣ PRIOR FALLS PREDICT INCIDENT FRACTURES INDEPENDENTLY OF FRAX: THE OSTEOPOROTIC FRACTURES IN MEN (MROS) STUDY
Presenting author: ‣ N. C. Harvey
Authors: ‣ A. Odén, ‣ E. Orwoll, ‣ J. Lapidus, ‣ T. Kwok, ‣ M. Karlsson, ‣ B. E. Rosengren, ‣ O. Ljunggren, ‣ C. Cooper, ‣ E. V. McCloskey, ‣ J. A. Kanis, ‣ C. Ohlsson, ‣ D. Mellström, ‣ H. Johansson
14.49
Podium
P850
‣ A NURSE-LED FRACTURE LIAISON SERVICE HAS POTENTIAL TO MAXIMISE THE DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS: RESULTS OF THE HOOF PROJECT
Presenting author: ‣ C. Armstrong
Authors: ‣ F. Heaney, ‣ S. R. Kearns, ‣ W.  Curtin, ‣ J. P. McCabe, ‣ C. G. Murphy, ‣ M. F. Delaney, ‣ J. J. Carey
14.56
Podium
P828
‣ RELATIONSHIPS BETWEEN DNA METHYLATION AND MUSCULOSKELETAL HEALTH FROM AN EPIGENOME WIDE ASSOCIATION STUDY: THE HERTFORDSHIRE COHORT
Presenting author: ‣ E. M.  Curtis
Authors: ‣ P. Titcombe, ‣ M. Edwards, ‣ S. Barton, ‣ P. Tsai, ‣ E. M. Dennison, ‣ J. Bell, ‣ T. Spector, ‣ A. Valdes, ‣ C. G. Bell, ‣ N. C. Harvey, ‣ C. Cooper
15.03
Podium
P115
‣ MICROSTRUCTURAL ANALYSIS OF SUBCHONDRAL BONE IN KNEE OSTEOARTHRITIS
Presenting author: ‣ L. A. Holzer
Authors: ‣ M. Kraiger, ‣ A. Leithner, ‣ G. Holzer
14.00 - 15.00
ESCEO SYMPOSIA
Meeting Room 6
ESCEO Working Group: Regulatory aspects of Rheumatoid Arthritis, in Europe, in 2017
Chairpersons: ‣ Maarten Boers, ‣ Pierre Miossec
‣ Welcome and introduction Jean‑Yves Reginster
‣ New EMA guidelines on clinical investigation of medicinal products for the treatment of RA Pierre Miossec
‣ ESCEO consensus advice to EMA regarding the guidelines Maarten Boers
‣ Discussion
‣ Conclusion Maarten Boers
Panel: ‣ Maarten Boers, ‣ Pierre Miossec, ‣ Thierry Thomas, ‣ Chris Edwards, ‣ Jean‑Yves Reginster
Meeting Room 5
Recommendations for the appropriate use of Hyaluronic Acid in the daily management of osteoarthritis
Chairpersons: ‣ Cyrus Cooper, ‣ François Rannou
‣ Welcome and scope of the problem Cyrus Cooper
‣ Mode of action of Hyaluronic Acid in osteoarthritis Gabriel Herrero‑Beaumont
‣ Recommendations for the appropriate use of Hyaluronic Acid in daily management of osteoarthritis François Rannou
‣ Discussion - Leader François Rannou
‣ Wrap-up and conclusion Cyrus Cooper
Panel: ‣ Roy D. Altman, ‣ Olivier Bruyère, ‣ Cyrus Cooper, ‣ Gabriel Herrero‑Beaumont, ‣ Tim McAlindon, ‣ Alberto Migliore, ‣ Karel Pavelka, ‣ François Rannou, ‣ Jean‑Yves Reginster, ‣ Daniel Uebelhart
14.00 - 15.00
ESCEO-FIRMO SYMPOSIUM
Meeting Room 3
The Research Agenda on Non-classical Actions of Cholecalciferol
Chairpersons: ‣ Maria Luisa Brandi, ‣ Maurizio Cutolo
‣ Actions of Cholecalciferol on Cardiovascular and Immune Functions Heike A. Bischoff‑Ferrari
‣ The Role of Cholecalciferol on Malignancy Francesco Bertoldo
‣ Discussion - Leader Maria Luisa Brandi
‣ Conclusion and Wrap-up Maurizio Cutolo
Panel: ‣ Francesco Bertoldo, ‣ Heike A. Bischoff‑Ferrari, ‣ Maria Luisa Brandi, ‣ Olivier Bruyère, ‣ Cyrus Cooper, ‣ Maurizio Cutolo, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Jean‑Yves Reginster, ‣ René Rizzoli
15.00 - 17.00
Auditorium A
SCIENTIFIC SESSION IV
Chairpersons: ‣ Bess Dawson‑Hughes, ‣ Stefania Maggi
15.00
Auditorium A
Plenary Lecture 7
‣ New perspectives in the treatment of frailty and sarcopenia Bruno Vellas
15.30
Auditorium A
Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards
‣ Jean‑Yves Reginster
15.35
Auditorium A
Presentation of the Best CNS Booth
‣ Jean‑Yves Reginster, ‣ Philippe Halbout
15.40
Auditorium A
Oral communications selected from abstracts
15.40
Auditorium A
OC30
‣ 25-HYDROXYVITAMIN D RESPONSE TO GESTATIONAL CHOLECALCIFEROL SUPPLEMENTATION IS ASSOCIATED WITH COMMON VITAMIN D RELATED GENETIC VARIANTS: FINDINGS FROM THE MAVIDOS TRIAL
Presenting author: ‣ R. J. Moon
Authors: ‣ N. C. Harvey, ‣ C. Cooper, ‣ S. D'angelo, ‣ E. M.  Curtis, ‣ S. R. Crozier, ‣ S. M. Robinson, ‣ N. J. Graham, ‣ J. W. Holloway, ‣ N. J. Bishop, ‣ S. Kennedy, ‣ A. T. Papageorghiou, ‣ I. Schoenmakers, ‣ R. Fraser, ‣ S. V. Gandhi, ‣ A. Prentice, ‣ H. Inskip, ‣ K. Javaid
15.50
Auditorium A
OC31
‣ FERMENTED DAIRY PRODUCTS CONSUMPTION IS ASSOCIATED WITH ATTENUATED CORTICAL BONE LOSS INDEPENDENTLY OF TOTAL CALCIUM, PROTEIN AND ENERGY INTAKES IN POSTMENOPAUSAL WOMEN
Presenting author: ‣ E. Biver
Authors: ‣ C. Durosier‑Izart, ‣ F. Merminod, ‣ T. Chevalley, ‣ S. Ferrari, ‣ R. Rizzoli
16.00
Auditorium A
OC32
‣ PUBLIC HEALTH AND ECONOMIC IMPACT OF VITAMIN D-FORTIFIED DAIRY PRODUCTS FOR FRACTURE PREVENTION IN FRANCE
Presenting author: ‣ M. Hiligsmann
Authors: ‣ N. Burlet, ‣ P. Fardellone, ‣ N. Al‑Daghri, ‣ J.‑Y. Reginster
16.10
Auditorium A
OC33
‣ THE DETERIORATION OF BONE MICROSTRUCTURE IS ASSOCIATED WITH INCIDENT FRAGILITY FRACTURE. THE OFELY STUDY.
Presenting author: ‣ R. D. Chapurlat
Authors: ‣ R. D. Chapurlat, ‣ R. Zebaze, ‣ Y. Peng, ‣ B. Lucy, ‣ E. Seeman, ‣ E. Sornay‑Rendu
16.20
Auditorium A
OC34
‣ CALCIUM INTAKE ASSESSMENT BY CALCIUM CALCULATOR IN AN ITALIAN POPULATION: VALIDATION STUDY
Presenting author: ‣ L. Vannucci
Authors: ‣ B. Pampaloni, ‣ L. Cianferotti, ‣ I. Faggiani, ‣ G. Gronchi, ‣ M. L. Brandi
16.30
Auditorium A
Plenary Lecture 8
‣ What do genetics studies bring to the understanding of osteoporosis? Maria Luisa Brandi
18.40 - 19.40
Cocktail offered by ESCEO and IOF to all recipients of prizes, awards, fellowships and scholarships - by invitation only